Brainomix Company

Since launching as a spin-out from the University of Oxford in 2010, Brainomix has developed award-winning, AI-powered imaging biomarkers, assisting physicians across the world to make better life-saving decisions. Brainomix seminal product, e-Stroke is a collection of tools that use state-of-the-art AI algorithms to support doctors by providing real-time interpretation of brain scans to help guide treatment and transfer decisions for stroke patients, allowing more patients to get the right treatment, in the right place, at the right time.

Connections from

Technology: Machine Learning
Industry: Data processing, Longevity Biomarkers
Headquarters: Oxford, Oxfordshire, United Kingdom
Founded Date: 2010-01-01
Employees Number: 11-50
Funding Status: Early Stage Venture
Investors Number: 6
Total Funding: 35017490
Estimated Revenue: $1M to $10M
Last Funding Date: 2021-12-16
Last Funding Type: Series B

Visit Website
info@brainomix.com
https://www.twitter.com/brainomix
Register and Claim Ownership